Controversy around nevirapine trials continues

Authors

Khabir Ahmed, Aga Khan UniversityFollow

Document Type

Article

Department

Ophthalmology

Abstract

The US Institute of Medicine (IOM), commissioned by the National Institutes of Health (NIH) to review its HIVNET 012 clinical trial, is set to release its findings in March.

Publication (Name of Journal)

Lancet Infectious Diseases

Recommended Citation

Ahmed, K. (2005). Controversy around nevirapine trials continues. Lancet Infectious Diseases, 5(2), 74.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_surg/446